REVANESSE® REVISE™ is optimized for structural support, dynamic correction, and patient satisfaction.

• Contains 23 mg/mL cross-linked hyaluronic acid (HA) for effective volumization

• Integrated with 0.3% lidocaine for enhanced comfort during injection

• Manufactured with Thixofix® technology for superior gel cohesivity and moldability

• Intended for use in high-movement zones like nasolabial folds and marionette lines

• Provides predictable, natural-looking results with long-lasting durability

REVANESSE® REVISE™ is indicated for the correction of moderate to severe facial wrinkles and folds, particularly:

• Nasolabial folds

• Marionette lines

• Oral commissures

• Chin wrinkles

• Dynamic wrinkles in mobile facial regions

Contraindications:

• Hypersensitivity to hyaluronic acid, lidocaine, or amide-type local anesthetics

• Active skin infections, inflammation, or dermatologic conditions at the injection site

• History of severe allergic reactions or anaphylaxis

• Pregnant or breastfeeding patients

• Use in patients under 22 years old

Potential Side Effects:

• Mild swelling, bruising, redness, tenderness at the injection site

• Temporary nodules or firmness

• Rare risks include vascular occlusion, inflammatory reactions, or hypersensitivity

REVANESSE® REVISE™ is a sterile, non-pyrogenic, viscoelastic gel composed of non-animal stabilized HA. It is specifically designed to combine resilience with adaptability, making it suitable for mobile areas where maintaining natural facial dynamics is essential.

Packaging:

• Supplied in a 1.2 mL pre-filled syringe

• Includes two sterile 27G ½” thin-wall needles

• Individually packaged and ready-to-use

Composition:

• Hyaluronic acid (HA): 23 mg/mL

• Lidocaine hydrochloride: 3 mg/mL (0.3%)

• Phosphate-buffered saline as excipient

• pH: 7.0

• Appearance: Clear, colorless gel

REVANESSE® REVISE™ should be administered by trained medical professionals experienced in dermal filler injection techniques. The product is intended for intradermal or subdermal injection using the linear threading, serial puncture, or fanning technique, depending on the area treated.

Usage Instructions:

• Clean and disinfect the treatment area before injection

• Use a 27G ½” needle provided in the packaging

• Inject slowly into the deep dermis or superficial subcutis

• Massage the area gently after injection to ensure even distribution

• Monitor the patient for any adverse reactions or complications

Post-Treatment Care:

• Advise patients to avoid extreme temperatures, intense physical activity, and alcohol for 24 hours

• Instruct to avoid massaging or applying pressure to the treated area for the first day

• Possible swelling or bruising typically resolves within a few days

Storage Conditions:

• Store at 2°C to 25°C

• Protect from light and freezing

• Do not use after expiration date